|
|
Possible food and drug interactions
Vaniqa has no known drug interactions. Make sure your doctor is aware of all medications and facial products you are using before you begin Vaniqa treatments.
|
What special precautions should I follow?
In case condition gets worse while you use the medicine, stop the medicine and contact your doctor.
If skin irritation occurs, reduce the frequency of treatments. If irritation cont
inues, stop using the medicine and contact your doctor.
If no improvement is seen after six months of treatment, stop using the medicine and contact your doctor.
|
What is this medicine
VANIQA (pronounced "VAN-i-ka") is a prescription medication applied to the skin for the reduction of unwanted facial hair in women. The active ingredient in VANIQA is eflornithine hydrochloride. VANIQ
A also contains ceteareth-20, cetearyl alcohol, dimethicone, glyceryl stearate, methylparaben, mineral oil, PEG-100 stearate, phenoxyethanol, propylparaben, stearyl alcohol and water.
|
|
|
|
Before Taking This Medicine
Breast-feeding¡XIt is not known whether Vaniqa passes into breast milk. Mothers who are taking this medicine and wish to breast¡Vfeed should discuss this with their doctor.
|
How should you take this medication?
This medicine comes with a patient instruction sheet. Read this sheet carefully and follow the directions. If you have any questions on how to use this medicine, be sure to ask your health care profes
sional.
This medicine is usually used on the face and nearby involved areas under the chin only. Do not get the medicine in your eyes, nose, or mouth. Rinse thoroughly with water and contact
your doctor if the medicine gets in the eyes
You need to continue your normal hair removal procedures while using this medicine, and the medicine should be applied at least five minutes after
the unwanted hair has been removed. You should wait until the medicine dries before applying cosmetics or sunscreen.
|
What side effects may occur?
In clinical trials, some women experienced minor and temporary skin irritations such as redness, stinging, burning, tingling or rash. If these persist, consult your doctor. Only 2% of subjects discont
inued studies due to side effects related to the use of VANIQA.
|
|
